Welcome Back

Google icon Sign in with Google
OR
I agree to abide by Pharmadaily Terms of Service and its Privacy Policy

Create Account

Google icon Sign up with Google
OR
By signing up, you agree to our Terms of Service and Privacy Policy
Instagram
youtube
Facebook

Global Program Clinical Head - Neuroscience (Early Programs)

Novartis
Novartis
10+ years
$225,400 to $418,600/year
10 July 1, 2025
Job Description
Job Type: Full Time Education: M.S/phD Skills: Causality Assessment, Clinical SAS Programming, Communication Skills, CPC Certified, GCP guidelines, ICD-10 CM Codes, CPT-Codes, HCPCS Codes, ICD-10 CM, CPT, HCPCS Coding, ICH guidelines, ICSR Case Processing, Interpersonal Skill, Labelling Assessment, MedDRA Coding, Medical Billing, Medical Coding, Medical Terminology, Narrative Writing, Research & Development, Technical Skill, Triage of ICSRs, WHO DD Coding

 

Global Program Clinical Head – Neuroscience (Early Programs) | Novartis – USA

Job Summary:

Novartis is seeking an experienced Global Program Clinical Head (GPCH) to lead early-phase neuroscience clinical development programs. This high-impact leadership role will shape and execute clinical strategies, oversee early development initiatives, and drive cross-functional collaboration to deliver life-changing therapies. If you're an MD or PhD with deep neuroscience expertise and global development experience, this is your opportunity to lead strategic innovation in the pharmaceutical industry.


Key Responsibilities:

  • Lead clinical strategy and development planning for neuroscience programs.

  • Align proof-of-concept studies and early development plans with the overall development roadmap.

  • Serve as clinical representative during pre- and post-PoC transitions and key decision points.

  • Drive the creation of clinical content for protocols, IBs, CSRs, and regulatory documents.

  • Collaborate with global functions including Regulatory, Medical Affairs, Safety, and Market Access.

  • Represent Novartis in external engagements with KOLs, regulatory bodies, and advisory boards.

  • Contribute to benefit-risk assessments, Core Data Sheets, PSURs, and product license renewals.

  • Develop and implement publication strategies and external communications in partnership with Medical Writing.


Required Skills & Qualifications:

  • MD, PhD, or equivalent with 10+ years of experience in clinical research or drug development (Phase I–IV).

  • Proven expertise in Neuroscience, with a deep understanding of neurology, neuroinflammation, or neurodegenerative disorders.

  • Strong grasp of GCP, clinical trial design, regulatory pathways, and submission documentation.

  • Demonstrated leadership in cross-functional global teams.

  • Experience with BD&L support, study design innovation, and regulatory authority engagement.

  • Preferred: MD/PhD in Neurology; Cell & Gene Therapy or Rare Disease exposure.


Perks & Benefits:

  • Competitive base salary: $225,400 to $418,600/year

  • Performance-based cash incentives and potential equity awards

  • Comprehensive health, life, and disability insurance

  • 401(k) with company match and contributions

  • Generous vacation, personal days, holidays, and additional leave options

  • Career development programs and global growth opportunities


Company Description:

Novartis is a global leader in reimagining medicine to improve and extend people’s lives. At the forefront of pharmaceutical innovation, Novartis fosters a collaborative culture that champions diversity and patient-centered breakthroughs in neuroscience, oncology, cardiovascular, and immunology. With a strong presence in over 140 countries, Novartis combines cutting-edge science with bold strategies to deliver transformative healthcare solutions.


Work Mode:

Remote (Distant Working Arrangement, USA) or Hybrid (East Hanover, NJ)


Call-to-Action:

Are you ready to drive strategic neuroscience programs that can change lives? Join Novartis as a Global Program Clinical Head and lead from the front in clinical innovation.
Apply now to shape the future of neuroscience drug development.